Join
Live feed
·
PRReleasevia Quantisnow
Eyenovia Inc. logo

Eyenovia Concludes Type A Meeting with FDA Related to MydCombi™ NDA Resubmission

ByQuantisnow·Wall Street's wire, on your screen.
EYEN· Eyenovia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEN (Eyenovia Inc.) and more on Quantisnow.